Skip to main content
Erschienen in: BMC Public Health 1/2024

Open Access 01.12.2024 | Systematic Review

The relationship between the price and demand of alcohol, tobacco, unhealthy food, sugar-sweetened beverages, and gambling: an umbrella review of systematic reviews

verfasst von: Robyn Burton, Casey Sharpe, Saloni Bhuptani, Mike Jecks, Clive Henn, Nicola Pearce-Smith, Sandy Knight, Marguerite Regan, Nick Sheron

Erschienen in: BMC Public Health | Ausgabe 1/2024

Abstract

Background

The WHO highlight alcohol, tobacco, unhealthy food, and sugar-sweetened beverage (SSB) taxes as one of the most effective policies for preventing and reducing the burden of non-communicable diseases. This umbrella review aimed to identify and summarise evidence from systematic reviews that report the relationship between price and demand or price and disease/death for alcohol, tobacco, unhealthy food, and SSBs. Given the recent recognition as gambling as a public health problem, we also included gambling.

Methods

The protocol for this umbrella review was pre-registered (PROSPERO CRD42023447429). Seven electronic databases were searched between 2000–2023. Eligible systematic reviews were those published in any country, including adults or children, and which quantitatively examined the relationship between alcohol, tobacco, gambling, unhealthy food, or SSB price/tax and demand (sales/consumption) or disease/death. Two researchers undertook screening, eligibility, data extraction, and risk of bias assessment using the ROBIS tool.

Results

We identified 50 reviews from 5,185 records, of which 31 reported on unhealthy food or SSBs, nine reported on tobacco, nine on alcohol, and one on multiple outcomes (alcohol, tobacco, unhealthy food, and SSBs). We did not identify any reviews on gambling. Higher prices were consistently associated with lower demand, notwithstanding variation in the size of effect across commodities or populations. Reductions in demand were large enough to be considered meaningful for policy.

Conclusions

Increases in the price of alcohol, tobacco, unhealthy food, and SSBs are consistently associated with decreases in demand. Moreover, increasing taxes can be expected to increase tax revenue. There may be potential in joining up approaches to taxation across the harm-causing commodities.
Begleitmaterial
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12889-024-18599-3.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
BMI
Body mass index
CI
Confidence interval
COI
Conflicts of interest
DALYs
Disability adjusted life years
HFSS
High in fat, salt and/or sugar
PED
Price elasticity of demand
RoB
Risk of bias
SSB
Sugar sweetened-beverage

Background

The profile of the leading causes of disease and death has changed over time, with conditions caused by commercial determinants of health progressively replacing infectious diseases, particularly in the global north [13]. Alcohol consumption, smoking, and excess weight are among the top 10 risk factors for disability adjusted life years (DALYs) globally, accounting for almost a fifth of all DALYs and over a quarter of deaths in 2019 [3]. In high-income countries, this increases to over a quarter of all DALYs and almost a third of all deaths.
Although an individual might only have one risk factor of alcohol use, smoking, or excess weight, many of these risks co-occur. For example, smokers are around three times more likely to drink at risky levels and up to 1.6 times more likely to have a poor diet [4, 5]. Multiple risks also cluster among the most deprived [4], and are therefore an important consideration for health inequalities. Multiple risks have clinical implications. A recent meta-analysis identified that the risk of disease and death from multiple risks is large, and for some outcomes, synergistic [6]. For example, the combined effect of risky alcohol consumption and excess weight on liver disease/death is 1.6 times greater than the sum of each risk on its own (95% confidence interval [CI] = 1.3, 1.9). Synergistic interaction was also seen for co-occurring risky alcohol consumption and smoking and oral cancers, where the combined effect was 3.8 times greater than the sum of each risk on its own (95% CI = 2.6, 5.4). Clearly, there are behavioural and clinical synergies between alcohol, smoking, and excess weight, but importantly, there are also policy synergies.
Current public health approaches to tackle alcohol consumption, smoking, and excess weight are somewhat siloed, as reflected in the global strategies across these three risks which include actions on price, marketing, and availability for each commodity on its own, but makes no reference to joining up these approaches to tackle multiple risks together in a comprehensive approach [7]. Within governments, health departments often have separate teams and policy approaches for alcohol, tobacco, and excess weight, and in finance departments, duty on related commodities are usually decided on a case-by-case basis. Many of the civil society organisations, charities, and medical academics who perform a vital advocacy role with policymakers also operate in these silos. Nonetheless, the evidence for the most effective and cost-effective approaches to preventing and reducing harm are broadly the same for tobacco, alcohol, and excess weight: increasing product price, restricting marketing, and reducing availability [7]. It is no coincidence that these comprise three of the four P’s of the marketing mix, the fourth being product, because the problems are generated by the products of commercially mediated organisations [8]. A requirement to reduce health harm is frequently in direct opposition to the generation of shareholder value [9].
Similarities in policy approaches to prevent and reduce alcohol-, tobacco-, and obesity-related harm can be seen across those implemented in the UK. For example, tobacco is subject to an annual tax escalator [10], and a sugar-sweetened beverage (SSB) tax came into force in 2018 [11]. Alcohol had a tax escalator between the years of 2008 and 2013 during which time deaths caused entirely by alcohol consumption (the directly attributable mortality) reduced, only to increase again when the measure was repealed [12, 13]. There are potential merits in considering policy areas together. For example, in the USA, increases in cigarette tax were associated with decreases in alcohol consumption among smokers [14]. In a UK study, the price elasticity of demand (PED) for alcohol was estimated to be -0.56, which reduced to -0.26 when the price of food was included in the analysis [15]. This suggests that pricing policies for alcohol may be undermined either if retailers offset an increase in alcohol price by decreasing the price of food, or if consumers have more disposable income due to the reductions in food price which can be spent on alcohol. Although price increases in medium-sugar drinks in the UK were associated with reductions in alcohol purchasing, increases in the price of high-sugar drinks were associated with an increase in purchasing of lager [16]. Finally, Australian modelling suggests that increasing alcohol tax is the most effective and cost-effective action to reduce obesity [17].
There is coherent logic in combining policy approaches for alcohol, tobacco, unhealthy food, and SSBs. Firstly, increases in price, restrictions on marketing, and reductions in availability are the key determinants of consumption and harm across all these policy areas [7]. Secondly, success in one policy area may lead to increased opportunities for harm in another if approached in isolation. For example, if alcohol sports sponsorship is banned, this could free up opportunities for sports sponsorship by fast food brands. Finally, data and evidence clearly demonstrate that multiple risks cluster, particularly among the poor, and this clustering results in a greater risk of disease and death [46]. As such, policy decisions that consider and respond to these risks together are likely to be more effective for preventing and reducing harm and narrowing health inequalities than policy decisions considering each risk in isolation.
Taxes on harmful commodities such as alcohol, tobacco, unhealthy foods, and SSBs are primarily levied to increase revenue but also play an important role in public health. Increasing the cost of the product relative to alternative spending choices and income reduces demand by decreasing affordability of the product which leads to lower levels of consumption and harm. Associated reductions in the cost of ill-health to society mean that well-designed taxes on harmful commodities can be a highly effective and cost-effective health intervention [7]. Standard economic theory predicts that a price increase will lead to a reduction in demand, which is typically measured using the PED (the percentage change in quantity demanded associated with a 1% change in price). Effectively designed taxes also provide a financial incentive for producers to reformulate their products to less harmful versions, for example, levying higher rates of tax on stronger alcohols might lead to reductions in product strength, and taxing excess fat in a product might lead to reductions in total fat content or replacement with alternative fats. Numerous reviews have examined the impact of price and taxes on consumption of alcohol, unhealthy food, SSBs, and smoking [1828]. Given the behavioural, clinical, and policy synergies across these commodities, it is opportune to synthesise existing evidence to understand the similarities and differences in consumer price responses and what this might mean for bringing together tax policies. To the author’s knowledge, there has been one umbrella review which has attempted to do this, however included countries in Latin America only [29]. Therefore, the aim of this umbrella review was to identify and summarise evidence from systematic reviews that report the relationship between price and demand or price and disease/death for alcohol, tobacco, unhealthy food, and SSBs in any country. Since gambling is a taxable commodity and there have been recent efforts to conceptualise gambling using a public health approach [30, 31], we also considered gambling.

Methods

The protocol for our umbrella review was pre-registered (PROSPERO CRD42023447429) [32] and our write up complies with the PRISMA 2020 reporting guidelines [33].

Eligibility criteria

The PICO used in our umbrella review is given in Appendix 1. Eligible studies were peer-reviewed systematic reviews (with/without meta-analysis) published between 1 January 2000 and 17 July 2023 in any country. The start date was chosen to ensure elasticity estimates were applicable to the current policy context. Systematic reviews were defined as those which searched ≥ 2 electronic databases and reported search terms and eligibility criteria. Study samples had to reflect the general population and could include adults or children. Our protocol originally stated only adult samples were eligible (≥ 18 years), however several eligible reviews combined findings from adults and children, and it was not always possible to separate the results. As such, we updated our eligibility criteria to include all ages, and where possible, report findings for different populations separately. To be eligible, reviews had to report a quantitative association between the price/tax of alcohol, tobacco, unhealthy foods (those high in fat, salt, sugar), SSBs, or gambling, and demand or disease/death. Reviews including observational and experimental designs were eligible (modelling and qualitative designs were ineligible). Although price can be influenced by mechanisms other than taxes, such as distribution monopolies or vouchers, these non-tax regulations were ineligible to increase comparability across the included reviews. Reviews funded by the alcohol, tobacco, gambling, or food/drink industry were ineligible, as were reviews undertaken by known industry-funded actors. Reviews not funded by industry actors, however included authors listing industry conflicts of interest (CoI) were included, as were reviews which did not list their funding source or CoIs. Only English-language reviews were eligible.

Information sources, search strategy and selection criteria

Ovid Medline, Ovid Embase, the Cochrane Database of Systematic Reviews, Epistemonikos, and EconLit (EBSCO) were searched from 1 Jan 2000 to 17 July 2023. An example search strategy is given in Appendix 2. IDEAS and EconPapers were searched from 1 Jan 2000 to 31 Dec 2022 because their results could not be downloaded, and we wanted to use reproducible searches when undertaking screening. Unpublished studies were not sought.
Records were screened using Rayyan [34]. Pilot title-and-abstract screening was undertaken by all researchers involved in screening on 100 records and indicated high levels of agreement (RB, SB, CH, MJ, MR, CS). Mean agreement was 92.7%, ranging from 90.0% to 97.0% across researcher pairs (Appendix 3). Thereafter, title-and-abstract screening was completed by a single researcher (RB), and a second checked a randomly selected 10% sample (SB, CH, MJ, CS). Although title-and-abstract screening was not undertaken in duplicate, if there was uncertainty about whether a record was eligible, we included it. There were high levels of agreement between screeners (ranging from 89.7% to 100% across researcher pairs), largely because it was easy to identify if a paper was a review or primary research study, and only systematic reviews were eligible. Full-text screening was completed in duplicate (RB, SB, CH, MJ, CS). Discrepancies were resolved by local discussion, consulting a third researcher if required.

Data collection process and data items

One researcher (RB) extracted data using a standardised template and any uncertainties were discussed with the research team collectively (template given in Appendix 4). A second researcher (MJ, SB) fully checked the data extraction of 60% of included reviews, and additional spot checks were undertaken of the remaining 40%. Only data pertaining to our research question was extracted. For example, for a review including studies evaluating the impact of tobacco tax and a smoking ban, only information pertaining to tax was extracted. Similarly, if a review included observational and modelling studies, only data pertaining to observational studies was extracted. We requested missing data from authors, making a maximum of three attempts. We did not request country- or population-level information for individual studies in a review when high-level information was given, for example, in a review including high-income countries without specifying the exact countries.

Study risk of bias assessment

In our protocol we proposed assessing risk of bias (RoB) using AMSTAR-2 [35], however, we changed our approach and used ROBIS [36]. This decision was guided by the fact that our definition of systematic reviews was taken from item 4 of the AMSTAR-2, and we excluded industry-funded research (item 16), rendering the tool less useful. We felt that ROBIS was preferable as we could consider the impact the methods had on the validity of findings, rather than assess whether a method had been correctly applied as is the case for AMSTAR-2 [37]. We note that AMSTAR-2 and ROBIS address similar, if not identical, methodological constructs and interrater reliability between the two tools is equivalent [38, 39]. RoB for all reviews was undertaken by a single researcher (CS) and a second researcher independently undertook a second appraisal of that review (RB, SB), and discrepancies were resolved by local discussion, consulting a third researcher if required. Completed RoB templates are available on request.

Effect measures

The key outcome measure for this review was the PED or equivalent measure for the relationship between price/tax and demand/health outcomes. Where a meta-analysis had been carried out, the combined effect size was reported overall and by age, sex, and deprivation (if available). For systematic reviews which reported the PED (or equivalent) for each included study but did not undertake a meta-analysis, we extracted the range. For systematic reviews which only reported the direction of PED (or equivalent) for each included study and not the magnitude, we extracted the number of estimates reporting an inverse, positive, or no association. Although this approach captures the direction and not magnitude of effect, and overlooks important information about variability within estimates, it enabled us to include a broader range of reviews while ensuring uniformity in data extraction and interpretation. Additionally, this was a pragmatic alternative to extracting all missing information from primary studies which was not possible within our resource and time constraints.

Synthesis methods

We undertook a narrative synthesis. Eligible reviews were grouped according to harmful commodity (alcohol, tobacco, unhealthy food, SSBs, gambling). Within these groups, we synthesised estimates for demand, and disease/death separately (measures of weight and body mass index (BMI) were included within the disease/death synthesis).

Reporting bias assessments

Overall, 12 reviews had some missing information on the countries of the included studies, 10 had missing information on the age of included populations, and three did not provide a detailed definition of unhealthy food. This missing information is indicated by NR (not reported) in Table 1. Definitions of unhealthy food used within reviews were highly varied, but commonly included foods high in fat, salt, and/or sugar (HFSS). Where definitions were vague (e.g. “unhealthy food”), we included these reviews, despite a lack of clarity about exactly what foods were in scope.
Table 1
Summary table of included systematic reviews. The table is ordered alphabetically within commodities (alcohol, tobacco, unhealthy food, and sugar-sweetened beverages). Studies are organised alphabetically, within type of harmful commodity
Reference [review type]
N databases
N studies
Search period
Included languages
Included countries
Industry funding and CoI
Included outcomes
ROBIS rating
Demand
Disease / death
Unhealthy food and soft drinks n = 31
Sugar-sweetened beverages n = 13
  Alagiyawanna 2015 [40] [SR]
6
9a
Inception-2013
ENG
HI = 9
None
O
O
U
  Andreyeva 2022 [21] [SRMA]
8
35b
Inception-2020
Any
HI = 27, MI = 8
None
O
 
U
  Backholer 2016 [41] [SR]
2
4c
Inception-2015
Any
HI = 4
None
O
O
L
  Cabrera Escobar 2013 [19] [SRMA]
5
12
2000–2013
ENG
HI = 10, MI = 2
None
O
O
H
  Hammaker 2022 [27] [SRMA]
12
17d
2000–2022
ENG
HI = 15, MI = 2
None
O
O
L
  Itria 2021 [42] [SR]
5
16e
2009–2019
ENG ESP
HI = 12, MI = 4
None
O
O
H
  Mackenbach 2022 [43] [SR]
3
1f
Inception-2021
ENG
MI = 1
None
 
O
H
  Nakhimovsky 2016 [44] [SR]
6
7g
1990–2016
ENG
MI = 7
None
O
O
L
  Nikniaz 2022 [45] [SR]
7
4h
2000–2021
ENG
HI = 4
None
O
 
L
  Pérez-Ferrer 2019 [46] [SR]
3
3i
1999–2017
ENG ESP PRT
MI = 3
None
O
 
H
  Redondo 2018 [47] [SR]
4
17
2011–2017
ENG ESP
HI = 15, MI = 2
Funding NR
O
 
H
  Teng 2019 [20] [SRMA]
4
22
Inception-2018
Any
HI = 18, MI = 4
None
O
 
L
  Von Philipsborn 2020 [48] [SR]
11
1j
Inception-2018
Any
HI = 1
CoI
O
 
L
Unhealthy food n = 9
 Andreyeva 2022 [49] [SR]
8
14k
Inception-2020
Any
HI = 8, MI = 6
None
O
O
H
 Dodd 2020 [50] [SR]
4
6l
2000–2019
Any
HI = 3, MI = 3
None
O
 
H
 Engler-Stringer 2014 [51] [SR]
9
1m
1995–2013
ENG
HI = 1
None
O
 
U
 Holsten 2009 [52] [SR]
5
1n
Inception-2006
ENG
HI = 1
None
 
O
H
 Lhachimi 2020 [53] [SR]
12
2
Inception-2009
Any
HI = 2
None
O
 
L
 Mah 2019 [54] [SR]
3
18o
Inception-2018
ENG
HI = 18
None
O
 
H
 Mizdrak 2015 [55] [SR]
5
6p
1980–2014
ENG
HI = 6
None
O
 
L
 Pfinder 2020 [56] [SR]
12
1
Inception-2019
Any
HI = 1
None
O
 
L
 Thow 2014 [57] [SR]
4
8q
2009–2012
ENG
HI = 8
Funding NR
O
 
H
Unhealthy food and sugar-sweetened drinks combined n = 9
 Afshin 2017 [18] [SRMA]
7
7r
1990–2014
NR
HI = 7
CoI
O
 
L
 Green 2013 [22] [SRMA]
6
28s
Inception-2011
ENG
HI = 17, MI = 7, LI = 3, NR = 1
None
O
 
L
 Mackenbach 2019 [58] [SR]
4
3t
Inception-2018
ENG NDL
HI = 2, MI = 1
None
O
 
L
 Maniadakis 2013 [59] [SR]
6
41u
1990–2013
ENG
HI = 38, MI = 3
Unclear funding
O
O
H
 Niebylski 2015 [60] [SR]
2
8v
2003–2013
ENG
HI = 7, NR = 1
CoI NR
O
O
U
 Powell 2009 [61] [SR]
4
7w
1990–2008
ENG
HI = 7
Funding/CoI NR
 
O
H
 Powell 2013 [62] [SR]
4
40x
2007–2012
ENG
HI = 40
CoI NR
O
O
H
 Thow 2010 [63] [SR]
3
6y
2000–2009
ENG
HI = 5, MI = 1
Funding NR
O
O
H
 Wright 2017 [64] [SR]
6
8z
1990–2015
ENG
NR = 8
None
O
 
H
Tobacco = 9
 Akter 2023 [65] [SR]
5
5aa
Inception-2021
ENG
HI = 4, MI = 1
None
 
O
L
 Guindon 2015 [23] [SRMA]
4
22
Inception-2013
Any
MI = 15, LI/MI NR = 5, HI = 2
CoI NR
O
 
L
 Hill 2014 [66] [SR]
12
7bb
2006–2010
ENG
HI = 6, NR = 1
None
O
 
H
 Jawad 2018 [24] [SRMA]
4
8
Inception-2017
Any
HI = 8
None
O
 
H
 Kjeld 2023 [67] [SR]
3
6
2011–2021
ENG
HI = 6
None
O
 
L
 McKay 2015 [68] [SR]
7
1cc
Inception-2013
Any
MI = 1
None
O
 
L
 Nazar 2021 [69] [SR]
5
28
Inception-2020
ENG
MI = 25, NR = 3
None
O
 
U
 Thomas 2008 [70] [SR]
16
42dd
Inception-2006
Any
HI = 41, MI = 1
None
O
 
L
 Wilson 2012 [71] [SR]
6
35ee
Inception-2009
Any
HI = 27, MI = 4, NR = 4
None
O
 
U
Alcohol n = 9
 Baldwin 2022 [72] [SR]
8
2ff
2010–2021
ENG
HI = 2
None
 
O
H
 Elder 2010 [73] [SR]
7
78
Inception-2005
ENG
HI = 78
CoI NR
O
O
L
 Kilian 2023 [25] [SRMA]
5
19gg
2000–2022
Any
HI = 15, MI = 3, NR = 1
CoI
O
 
L
 Kõlves 2020 [74] [SR]
9
8hh
Inception-2019
ENG
HI = 6, MI = 2
None
 
O
L
 Li 2015 [75] [SR]
5
2ii
1980–2013
ENG CHN
MI = 2
CoI NR
O
O
U
 Scott 2017 [76] [SR]
7
1jj
Inception-2015
Any
HI = 1
None
O
 
L
 Wagenaar 2009 [26] [SRMA]
9
112
Inception-2009
ENG
NR = 12
None
O
 
H
 Wagenaar 2010 [28] [SRMA]
12
50
Inception-2009
ENG
HI = 47, NR = 3
CoI NR
 
O
L
 Wilson 2014 [77] [SR]
11
2kk
1992–2013
ENG
HI = 2
None
 
O
H
Multiple commodities n = 1
 Miracolo 2021 [29] [SR]
5
14ll
2000–2018
ENG ESPN
MI = 10
HI = 3, NR = 1
Funding NR
O
O
H
Only data pertaining to our research question and eligibility criteria was extracted. As such, the number of studies synthesised in our review might not match the number of studies listed in the published review. The number of studies listed in published reviews was as follows: a18, b86, c11, d51, e21, f23, g9, h59, I84, j58, k54, l18, m26, n7, o86, p8, q43, r26, s136, t43, u55, v78, w9, x47, y24, z102, aa144, bb84, cc80, dd84, ee84, ff31, gg39, hh19, ii21, jj48, kk23, ll34
CHN Chinese, CoI conflict of interest, ENG English, ESPN Spanish, H high risk of bias, L low risk of bias, PRT Portuguese, NDL Danish, NR not reported, ROBIS risk of bias in systematic reviews, SR systematic review, SRMA systematic review and meta-analysis, U unclear risk of bias
We requested missing information from four authors regarding the number and names of databases used [70], search strategies [70, 76, 78], and language-based eligibility criteria [18] and received requested information from two authors [70, 76]. We did not receive a search strategy for one review [78] and, because our eligibility criteria for systematic reviews requires reporting search terms, it was then excluded.
To explore the potential impact of industry CoIs or missing CoI or funding information, we compared reviews without industry funding/CoIs to reviews with industry CoIs or missing information.

Interpretation of results

Through informal verbal discussions within the research team, interpretation of the results was guided by the four components in GRADE-CERQual (methodological limitations, coherence, adequacy, and relevance) [79]. This helped us to take a structured approach to synthesising the data across the different commodities and frame the discussion. Methodological limitations were assessed using the ROBIS scores, focusing on sources of bias and what that meant for the findings of the included reviews. When assessing coherence of findings, we did this between reviews within a single commodity of interest (such as alcohol), as well as across reviews of different commodities (alcohol, tobacco, unhealthy food, and SSBs). This helped us identify whether the data from contributing studies provided a plausible explanation for the relationship between price and demand not only for specific products, but as a general mechanism of action. Our discussions about the adequacy of the data revealed the limitations of using review-level evidence which lacked a richness, however had the trade-off that a larger quantity of data was included (noting overlap in the primary studies included across the reviews). Relevance was considered while undertaking screening, since our eligibility criteria were restricted to typical populations and settings so their findings could be more easily generalised to the general population.

Results

Study selection

The search returned 5,185 records, of which 3,863 were screened for eligibility using title-and-abstract (Fig. 1). A total of 185 were screened using full-texts, and 50 were eligible and included in this umbrella review. Examples of excluded records and reasons for their exclusion are given in Appendix 5.

Study characteristics

A summary of the commodities of interest, included outcomes, and methodological aspects covered across the included systematic reviews is given in Table 1. Of the 50 included reviews, 31 reported on unhealthy food or SSBs [1822, 27, 4058, 6064, 80], nine reported on tobacco [23, 24, 6571], nine on alcohol [25, 26, 28, 7277], and one on multiple outcomes (alcohol, tobacco, and SSBs) [29]. Included reviews on unhealthy food and/or SSBs were generally published more recently than reviews on alcohol and tobacco: almost half of the alcohol and tobacco reviews were published before 2014, whereas almost half of the unhealthy food and/or SSBs reviews were published after 2017 (Appendix 6). No reviews were identified for gambling. Most reviews reported on the price-demand response (n = 42) with fewer reporting on the price-disease/death response (n = 22). Over 80% of reviews included mostly high-income countries, and there was a mix of adult/child samples (Table 1).

Risk of bias in studies

Of the 50 systematic reviews included in this umbrella review, 24 were rated as having a low RoB, 18 as having a high RoB, and eight as having an unclear RoB (Fig. 2, Appendix 7). Common sources of bias included poor handling or reporting of variability and robustness of findings, and a lack of detail or ambiguity about screening, data collection, and quality appraisal procedures. RoB scores for each review and by commodity (alcohol, tobacco, and unhealthy food/SSBs) are available in Appendix 7 which includes a description of the main sources of bias for each review and our approach to scoring.

Results of individual studies

An overview of included systematic reviews which undertook meta-analyses for the relationship between price and demand are given in Table 2, with a visual depiction in Fig. 3. An overview of included systematic reviews which undertook a narrative synthesis are given in Appendix 8 (for demand), Appendix 9 (for disease/death) and Appendix 10 (for impacts on deprived groups).
Table 2
Overview of findings reported in included systematic reviews which undertook meta-analyses. Tables are ordered within commodities from low to high risk of bias
Study author (ref); search period
Study design n; population n
Intervention
Subgroup (if applicable)
Pooled PED (95% CI)
ROBIS score
Systematic reviews with meta-analyses for SSBs n = 4
 Afshin 2017 [18]
1990 – 2014
Observational = 7
All ages = 3, children = 3, adults = 1
SSB and other unhealthy drinks (NS) price/tax
SSBs
-0.67 (-1.04, -0.31)
Low RoB
Other unhealthy drinks
-0.48 (-0.81, -0.16)
 Andreyeva 2022 [21]
Inception – 2020
Observational = 35
NR, all ages were eligible
SSB price/tax
SSB sales
-1.59 (-2.11, -1.08)
Low RoB
SSB consumption
-3.78 (-8.86, 1.30)
 Teng 2019 [20]
Inception – 2018
Observational = 22
All ages = 22
SSB tax
Overall
-1.00 (-0.50, -1.47)
Low RoB
USA states (excluding Berkely)
-0.98 (-0.89, -1.07)
Berkeley
-0.95 (-0.93, -0.98)
Mexico
-0.91 (-0.90, -0.92)
Catalonia
-0.86 (-0.80, -0.93)
France
-0.84 (-0.84, -0.85)
Chile
-0.76 (-0.51, -1.15)
 Cabrera Escobar 2013 [19]
2000 – 2013
Observational = 12
All ages = 8, adults = 3, children = 1
SSB price/tax
-
-1.30 (-1.09, -1.51)
High RoB
Systematic reviews with meta-analyses for unhealthy foods and SSBs combined n = 2
 Afshin 2017 [18]
1990 – 2014
Observational = 7
All ages = 3, children = 3, adults = 1
Unhealthy food (NS) and SSB price/tax
All unhealthy food and SSBs
-0.60 (-0.78, -0.42)
Low RoB
 Green 2013 [22]
Inception – 2011
Observational = 28
NR, all ages were eligible
Sweets, confectionary and SSB price/tax
Low-income countries
-0.74 (-0.82, -0.65)
Low RoB
Middle-income countries
-0.68 (-0.77, -0.59)
High-income countries
-0.56 (-0.65, -0.48)
Lowest-income households
-0.87 (-1.06, -0.70)
Highest-income households
-0.73 (-0.91, -0.55)
Systematic reviews with meta-analyses for unhealthy foods n = 1
 Afshin 2017 [18]
1990 – 2014
Observational = 7
All ages = 3, children = 3, adults = 1
Unhealthy food (NS)
Fast foods
-0.32 (-0.51, -0.13)
Low RoB
Other unhealthy food
-0.88 (-1.16, -0.60)
Tobacco systematic reviews with meta-analyses n = 2
 Guindon 2015 [23]
Inception – 2013
Observational = 22
All ages = 22
Tobacco price/tax
Short-run
-0.31 (-0.39, -0.24)
Low RoB
Long-run
-0.43 (-0.51, -0.35)
 Jawad 2018 [24]
Inception – 2017
Observational = 8
NR, all ages were eligible
Cigars and hand-rolled tobacco price/tax
Cigars
-0.83 (-1.38, -0.29)
High RoB
Hand-rolled tobacco
-0.64 (-0.84, -0.43)
Alcohol systematic reviews with meta-analyses n = 2
 Kilian 2023 [25]
2000 – 2022
Observational = 19
All ages = 18, adults = 1
Alcohol price/tax
-
-0.11 (-0.15, -0.07)a
Low RoB
 Wagenaar 2009 [26]
Inception – 2009
Observational = 112
NR, all ages were eligible
Alcohol price/tax
All alcohol: aggregate studies
-0.44 (-0.54, -0.34)
High RoB
All alcohol: individual studies
-0.03 (-0.05, -0.02)
Beer: aggregate studies
-0.17 (-0.22, -0.12)
Beer: individual studies
-0.12 (-0.22, -0.02)
Wine: aggregate studies
-0.30 (-0.36, -0.23)
Wine: individual studies
-0.14 (-0.26, -0.01)
Spirits: aggregate studies
-0.29 (-0.34, -0.23)
Spirits: individual studies
-0.10 (-0.17, -0.02)
Only data pertaining to our research question and eligibility criteria was extracted. For example, if a review undertook a meta-analysis of studies evaluating both the impact of a tobacco tax and a smoking ban, only information pertaining to tax was extracted. As such, the number of studies listed in this table might not match the numbers listed in the published review. Additional information about each review can be seen in Table 1. We identified an additional meta-analysis which was not included in this table because it did not report PED, however the results were consistent and showed that an SSB tax was associated with a decrease in demand [27]
CI confidence interval, NR not reported, NS not specified, PED price elasticity of demand, RoB risk of bias, ROBIS risk of bias in systematic reviews, SSB sugar-sweetened beverage
aThe review reports change for a 100% increase in price which we have converted to a 1% change for comparability across reviews

Results of syntheses

The relationship between price and demand

The included systematic reviews find that increases in the price of alcohol, tobacco, unhealthy food, or SSBs are associated with decreases in demand, notwithstanding variation in the size of effect across commodities or populations (Fig. 3, Appendix 8). An inverse association between price and demand was consistently seen across all outcomes. Looking across the included meta-analyses, a 10% increase in product price was associated with a median reduction in demand of 9.1% for SSBs [1821], 6.0% for unhealthy food [18], 5.4% for tobacco [23, 24], and 1.4% for alcohol [25, 26]. It should be noted that there will be overlap in the studies contributing to these estimates which we did not quantify. Where reviews reported the differential impact of price on different groups, the evidence generally suggests that more deprived groups are more price responsive than less deprived groups (Appendix 10).

The relationship between price and disease or death

Compared to the body of evidence reporting the relationship between price and demand, the body reporting the relationship between price and disease/death was smaller (Appendix 9). Across the alcohol reviews, inverse relationships were most consistently seen for outcomes which are wholly caused by alcohol (those with an alcohol attributable fraction of 1), such as alcohol-related liver disease or alcohol dependence [28, 7375]. The direct reporting of these outcomes enables accurate tracking of trends, whereas trends in partially attributable outcomes may be obscured by other factors. One systematic review including a small number of estimates suggested an increase in the price of tobacco was associated with a decrease in cases of lung cancer, respiratory disease, and cardiovascular disease, however there was large between-studies variability [65]. An emerging body of evidence supports an inverse association between the price of SSBs and the prevalence of dental caries [27, 43].

Reporting biases

Table 1 shows funding and CoI information listed in reviews. When we compared the results of reviews which did not included a funding or CoI statement (n = 11), had industry CoIs (n = 3), or had unclear funding (n = 1), to the results of reviews with no industry funding or CoIs (n = 35), we found no discernible differences in the magnitude or direction of associations.

Discussion

We undertook a comprehensive umbrella review of systematic reviews to identify the relationship between the price of alcohol, tobacco, unhealthy food, SSBs, or gambling, and demand or disease/death. Despite alcohol and tobacco being taxable commodities for centuries [81, 82], we identified fewer reviews in these areas compared to reviews on unhealthy food and SSBs which have only recently been viewed as taxable commodities [83, 84]. We did not identify any reviews for gambling. Published evidence on the effectiveness of tax as a measure to prevent and reduce gambling-related harms is limited, however its potential use as a public health tool has been debated in recent scientific papers and the results of an e-Delphi consensus study highlight them as a possibly effective public health policy [31]. Goyder and colleagues argued that gambling taxation might work in a similar way to alcohol, tobacco, and SSB tax [85], and Sulkunen and colleagues suggest that increases in gambling tax might make it less profitable to providers, which may reduce their interest in expanding [86]. Others have suggested that gambling taxes might have a harmful impact by increasing the losses of gamblers, and it is excessive losses which mediate gambling-related harm, not the gambling itself [87]. UK estimates of the PED for gambling range from -1.5 for remote gaming to -0.5 for betting pools [88].
Our review clearly demonstrates that, at the most basic level, price interacts with income to affect demand, such that price increases of alcohol, tobacco, unhealthy food, or SSBs are associated with reductions in demand. Such consistency in findings clearly highlights the fundamental role of tax as a public health policy. Our review suggests that a 10% increase in product price is associated with reductions in demand in the order of 9.% for SSBs, 6% for unhealthy food, 5% for tobacco, and 1% for alcohol. This inverse relationship was most consistently seen for alcohol, and least consistently for SSBs. The relationship between price and demand was seen among adult and child populations, with some review-level evidence to suggest that children and young people were more price responsive in the case of tobacco [67, 71], as might also be the case for SSBs [20], although most reviews did not explicitly make this comparison. Although most reviews included research from high-income countries, where studied, the inverse price-demand relationship was seen across low-, middle-, and high-income countries. There was a lack of research on heavy consumers. Although the reviews present a consistent overall picture of the impact of price/tax on demand, there was large variation in estimates across the individual studies which may relate to methodological differences across studies. Elasticity estimates also vary over time, with some suggestion that products have become less price elastic, which probably reflects increasing affluence as products become more affordable [89].
Reviews on tobacco, unhealthy food, and SSBs generally provided evidence that lower income, education, or socioeconomic status groups were more price responsive compared to their less deprived counterparts for example [27, 47, 55, 66], but no alcohol reviews included this evidence. Nonetheless, data from primary research studies suggests that more deprived drinkers are more price responsive [90, 91]. A common argument against the imposition of taxes is that they may have a proportionally greater financial impact on people with lower incomes relative to those with higher incomes. However, lower income groups as a whole reap greater health benefits [92, 93]. To the extent that lower income individuals are more price sensitive, they will be more likely to cut back on the intake of taxed commodities, often starting from a higher level of consumption, and thus experience greater health gains.
Raising taxes not only has direct public health benefits but can also generate considerable revenue for governments. If price increases do not respond proportionately to tax increases, (i.e. if the PED < 1), government revenue will increase when taxes increase because the decrease in consumption is more than offset by the extra tax paid by those who continue to purchase the taxed product. Our review suggests this is the case for alcohol, tobacco, and unhealthy food, however some of the PED estimates for SSBs exceed one, suggesting government revenue might reduce because of the greater demand response. Nonetheless, SSB taxes are not widely implemented so any revenue generated by their introduction is revenue that would not have otherwise existed. Increased revenue associated with tax increases may go some way in compensating for the societal and human costs associated with alcohol, smoking, and excess weight.
Risky alcohol use, smoking, and excess weight, commonly co-occur and cluster in the most deprived [4, 5]. Multiple risks also result in large risks of disease or death which are synergistic in the case of alcohol and excess weight for liver disease and alcohol and smoking for oral cancers [6]. From these perspectives (behavioural and clinical), there is clear rationale for joining up policy approaches to prevent and reduce harm. The results of our review further highlight the potential of joining up policy approaches, specifically taxation and price increases. While taxation shares the same mechanism of action for alcohol, tobacco, unhealthy food, and SSBs, it should be noted that the end-goal of policy implementation might differ. An appropriate goal for smoking is usually complete abstinence, whereas for alcohol, the aim is to decrease the number of people drinking at levels which increase their risk of health harm (noting abstinence might be the goal for people with alcohol dependence). Although the WHO have recently recognised that there is no safe level of alcohol consumption [94], in practice, most countries have developed low-risk drinking guidelines at levels above zero which are typically set at what is considered to be an acceptable level of risk [9597]. Diet however is multifaceted and may comprise aspects such as consuming fruit and vegetables, whole-grain high-fibre foods, and limiting sugar, fat, and salt. While this umbrella review has demonstrated the effectiveness of tax as a public health measure for alcohol, tobacco, unhealthy food, and SSBs in isolation, it has not been able to explore the impact of simultaneous tax increases across these commodities, namely because the evidence does not exist. Future research should aim to understand the potential public health impact of a holistic approach to tax policy spanning these commodities.

Strengths and limitations

We identified reviews according to a pre-published protocol, focusing on the harmful commodities responsible for the largest burden of overall ill-health. As with all types of information retrieval there is a risk of overlooking relevant literature. Although title-and-abstract screening was not done in duplicate, levels of agreement between raters was high, thereby reducing this risk. Additionally, we consulted with topic experts at the Office for Health Improvement and Disparities to ensure there were no major oversights. Several reviews were based on a similar pool of primary studies and are therefore not independent. We did not attempt to identify levels of overlap between reviews however duplication is likely to be highest in reviews of SSBs given the larger numbers of reviews with similar aims and eligibility criteria.
The amount of detail included in reviews was highly variable limiting our ability to meaningfully compare effect sizes across reviews. To overcome this, where exact estimates were not reported, we extracted the number of estimates reporting an inverse, positive, or no association. Although this enabled us to include a wider number of relevant reviews and develop an understanding of the consistency of directional effects, this limited our ability to understand the magnitude of effect or capture explanations for mixed or null effects. Nonetheless, we gained insight into the magnitude of effect from meta-analyses and the range in PED in systematic reviews which did report effect sizes.
The impact of price increases can be mitigated by consumers substituting products which have experienced a price increase for others which have not. Exploring this ‘cross-price elasticity’ was outside the scope of this review, however we note evidence that UK consumers tend to treat off-trade wine and cider as substitutes, meaning consumers are happy to switch from wine to cider if the price of wine increases [98], and higher prices for SSBs are associated with an increased demand for fruit juice [19]. Increases in the price of cigarettes has been shown to lead to substantial increases in per-capita sales of nicotine replacement products [99], and with the advent of electronic-cigarettes, emerging research suggests they are partially substitutable for combustible cigarettes [100]. Such commodity shifting should be kept in mind when implementing any taxation policy. We also note that our review only demonstrates the effectiveness of price policy for alcohol, tobacco, unhealthy food, and SSBs in isolation, and does not consider evidence of the impact of a combined taxation approach.
We did not assess the risk of bias in individual studies included in each review, and only undertook these appraisals at the review level. We note that 19 of the 50 reviews (38%) had a high RoB and a further eight had an unclear RoB (16%), which should be borne in mind when considering the validity of the results. It is possible that researchers had flaws in their methodological approach, however, standardised reporting guidelines such as PRISMA were only published in 2009 (with an update in 2020) and their use has picked up greatly in more recent years [33, 101]. Some of the biases in reviews arose due to reporting issues where information was either not included, or unclear, so it is likely that some of these low scores relate to reporting rather than actual methodological quality. This would especially be the case for older reviews that were published before PRISMA was widely adopted, which in our sample were more likely to be reviews on tobacco or alcohol.

Conclusion

While risky alcohol consumption, smoking, and excess weight all represent a substantial public health burden in and of themselves, there are clear behavioural, clinical, and policy synergies across these risks. The evidence supports tax/price increases as effective policies for reducing demand, which suggests there might be merit in a joined-up approach to tax, with the treasury representing an arbiter of public health and the National Health Service (NHS) costs.

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Supplementary Information

Literatur
1.
Zurück zum Zitat Kickbusch I, Allen L, Franz C. The commercial determinants of health. Lancet Glob Health. 2016;4(12):e895–6.PubMedCrossRef Kickbusch I, Allen L, Franz C. The commercial determinants of health. Lancet Glob Health. 2016;4(12):e895–6.PubMedCrossRef
2.
Zurück zum Zitat de Lacy-Vawdon C, Livingstone C. Defining the commercial determinants of health: a systematic review. BMC Public Health. 2020;20:1–16. de Lacy-Vawdon C, Livingstone C. Defining the commercial determinants of health: a systematic review. BMC Public Health. 2020;20:1–16.
4.
Zurück zum Zitat Meader N, King K, Moe-Byrne T, Wright K, Graham H, Petticrew M, et al. A systematic review on the clustering and co-occurrence of multiple risk behaviours. BMC Public Health. 2016;16(1):1–9.CrossRef Meader N, King K, Moe-Byrne T, Wright K, Graham H, Petticrew M, et al. A systematic review on the clustering and co-occurrence of multiple risk behaviours. BMC Public Health. 2016;16(1):1–9.CrossRef
5.
Zurück zum Zitat Burton R, Sharpe C, Sheron N, Henn C, Knight S, Wright VM, et al. The prevalence and clustering of alcohol consumption, gambling, smoking, and excess weight in an English adult population. Prev Med. 2023;175:107683.PubMedCrossRef Burton R, Sharpe C, Sheron N, Henn C, Knight S, Wright VM, et al. The prevalence and clustering of alcohol consumption, gambling, smoking, and excess weight in an English adult population. Prev Med. 2023;175:107683.PubMedCrossRef
6.
Zurück zum Zitat Burton R, Fryers PT, Sharpe C, Clarke Z, Henn C, Hydes T, et al. The independent and joint risks of alcohol consumption, smoking, and excess weight on morbidity and mortality: a systematic review and meta-analysis exploring synergistic associations. Public Health. 2024;226:39–52.PubMedCrossRef Burton R, Fryers PT, Sharpe C, Clarke Z, Henn C, Hydes T, et al. The independent and joint risks of alcohol consumption, smoking, and excess weight on morbidity and mortality: a systematic review and meta-analysis exploring synergistic associations. Public Health. 2024;226:39–52.PubMedCrossRef
7.
Zurück zum Zitat World Health Organization. ‘Best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases. 2017. World Health Organization. ‘Best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases. 2017.
8.
Zurück zum Zitat Moodie R, Stuckler D, Montiero C, Sheron N, Neal B, Thamarangsi T, et al. Prevention of non-communicable diseases and the tobacco, alcohol and ultra processed food and drink industries. Lancet. 2012. in press. Moodie R, Stuckler D, Montiero C, Sheron N, Neal B, Thamarangsi T, et al. Prevention of non-communicable diseases and the tobacco, alcohol and ultra processed food and drink industries. Lancet. 2012. in press.
9.
Zurück zum Zitat Hastings G. The marketing matrix: how the corporation gets its power - and how we can reclaim it. 2012. Hastings G. The marketing matrix: how the corporation gets its power - and how we can reclaim it. 2012.
13.
Zurück zum Zitat Sheron N, Gilmore I. Effect of policy, economics, and the changing alcohol marketplace on alcohol related deaths in England and Wales. BMJ. 2016;353:i1860.PubMedCrossRef Sheron N, Gilmore I. Effect of policy, economics, and the changing alcohol marketplace on alcohol related deaths in England and Wales. BMJ. 2016;353:i1860.PubMedCrossRef
14.
Zurück zum Zitat Young-Wolff KC, Kasza KA, Hyland AJ, McKee SA. Increased cigarette tax is associated with reductions in alcohol consumption in a longitudinal U.S. sample. Alcoholism. 2014;38(1):241–8.PubMedCrossRef Young-Wolff KC, Kasza KA, Hyland AJ, McKee SA. Increased cigarette tax is associated with reductions in alcohol consumption in a longitudinal U.S. sample. Alcoholism. 2014;38(1):241–8.PubMedCrossRef
15.
Zurück zum Zitat Moore SC, Orpen B, Smith J, Sarkar C, Li C, Shepherd J, et al. Alcohol affordability: implications for alcohol price policies. A cross-sectional analysis in middle and older adults from UK Biobank. J Public Health. 2022;44(2):e192–202.CrossRef Moore SC, Orpen B, Smith J, Sarkar C, Li C, Shepherd J, et al. Alcohol affordability: implications for alcohol price policies. A cross-sectional analysis in middle and older adults from UK Biobank. J Public Health. 2022;44(2):e192–202.CrossRef
16.
Zurück zum Zitat Quirmbach D, Cornelsen L, Jebb SA, Marteau T, Smith R. Effect of increasing the price of sugar-sweetened beverages on alcoholic beverage purchases: an economic analysis of sales data. J Epidemiol Community Health. 2018;72(4):324–30.PubMedCrossRef Quirmbach D, Cornelsen L, Jebb SA, Marteau T, Smith R. Effect of increasing the price of sugar-sweetened beverages on alcoholic beverage purchases: an economic analysis of sales data. J Epidemiol Community Health. 2018;72(4):324–30.PubMedCrossRef
17.
Zurück zum Zitat Ananthapavan J, Sacks G, Brown V, Moodie M, Nguyen P, Veerman L, et al. Priority-setting for obesity prevention—the Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study. PLoS ONE. 2020;15(6):e0234804.PubMedPubMedCentralCrossRef Ananthapavan J, Sacks G, Brown V, Moodie M, Nguyen P, Veerman L, et al. Priority-setting for obesity prevention—the Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study. PLoS ONE. 2020;15(6):e0234804.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Afshin A, Penalvo JL, Del Gobbo L, Silva J, Michaelson M, O’Flaherty M, et al. The prospective impact of food pricing on improving dietary consumption: a systematic review and meta-analysis. PLoS ONE. 2017;12(3):e0172277.PubMedPubMedCentralCrossRef Afshin A, Penalvo JL, Del Gobbo L, Silva J, Michaelson M, O’Flaherty M, et al. The prospective impact of food pricing on improving dietary consumption: a systematic review and meta-analysis. PLoS ONE. 2017;12(3):e0172277.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Cabrera Escobar MA, Veerman JL, Tollman SM, Bertram MY, Hofman KJ. Evidence that a tax on sugar sweetened beverages reduces the obesity rate: a meta-analysis. BMC Public Health. 2013;13:1–10.CrossRef Cabrera Escobar MA, Veerman JL, Tollman SM, Bertram MY, Hofman KJ. Evidence that a tax on sugar sweetened beverages reduces the obesity rate: a meta-analysis. BMC Public Health. 2013;13:1–10.CrossRef
20.
Zurück zum Zitat Teng AM, Jones AC, Mizdrak A, Signal L, Genç M, Wilson N. Impact of sugar-sweetened beverage taxes on purchases and dietary intake: Systematic review and meta-analysis. Obes Rev. 2019;20(9):1187–204.PubMedPubMedCentralCrossRef Teng AM, Jones AC, Mizdrak A, Signal L, Genç M, Wilson N. Impact of sugar-sweetened beverage taxes on purchases and dietary intake: Systematic review and meta-analysis. Obes Rev. 2019;20(9):1187–204.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Andreyeva T, Marple K, Marinello S, Moore TE, Powell LM. Outcomes following taxation of sugar-sweetened beverages: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(6):e2215276.PubMedPubMedCentralCrossRef Andreyeva T, Marple K, Marinello S, Moore TE, Powell LM. Outcomes following taxation of sugar-sweetened beverages: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(6):e2215276.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Green R, Cornelsen L, Dangour AD, Turner R, Shankar B, Mazzocchi M, et al. The effect of rising food prices on food consumption: systematic review with meta-regression. BMJ. 2013;346:f3703.PubMedPubMedCentralCrossRef Green R, Cornelsen L, Dangour AD, Turner R, Shankar B, Mazzocchi M, et al. The effect of rising food prices on food consumption: systematic review with meta-regression. BMJ. 2013;346:f3703.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Guindon GE, Paraje GR, Chaloupka FJ. The impact of prices and taxes on the use of tobacco products in Latin America and the Caribbean. Am J Public Health. 2015;105(3):e9–19.PubMedPubMedCentralCrossRef Guindon GE, Paraje GR, Chaloupka FJ. The impact of prices and taxes on the use of tobacco products in Latin America and the Caribbean. Am J Public Health. 2015;105(3):e9–19.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Jawad M, Lee JT, Glantz S, Millett C. Price elasticity of demand of non-cigarette tobacco products: a systematic review and meta-analysis. Tob Control. 2018;27(6):689–95.PubMedCrossRef Jawad M, Lee JT, Glantz S, Millett C. Price elasticity of demand of non-cigarette tobacco products: a systematic review and meta-analysis. Tob Control. 2018;27(6):689–95.PubMedCrossRef
25.
Zurück zum Zitat Kilian C, Lemp JM, Llamosas-Falcón L, Carr T, Ye Y, Kerr WC, et al. Reducing alcohol use through alcohol control policies in the general population and population subgroups: a systematic review and meta-analysis. Eclinicalmedicine. 2023;59:101996.PubMedPubMedCentralCrossRef Kilian C, Lemp JM, Llamosas-Falcón L, Carr T, Ye Y, Kerr WC, et al. Reducing alcohol use through alcohol control policies in the general population and population subgroups: a systematic review and meta-analysis. Eclinicalmedicine. 2023;59:101996.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Wagenaar AC, Salois MJ, Komro KA. Effects of beverage alcohol price and tax levels on drinking: a meta-analysis of 1003 estimates from 112 studies. Addiction. 2009;104(2):179–90.PubMedCrossRef Wagenaar AC, Salois MJ, Komro KA. Effects of beverage alcohol price and tax levels on drinking: a meta-analysis of 1003 estimates from 112 studies. Addiction. 2009;104(2):179–90.PubMedCrossRef
27.
Zurück zum Zitat Hammaker J, Anda D, Kozakiewicz T, Bachina V, Berretta M, Shisler S, et al. Systematic review on fiscal policy interventions in nutrition. Front Nutr. 2022;9:967494.PubMedPubMedCentralCrossRef Hammaker J, Anda D, Kozakiewicz T, Bachina V, Berretta M, Shisler S, et al. Systematic review on fiscal policy interventions in nutrition. Front Nutr. 2022;9:967494.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Wagenaar AC, Tobler AL, Komro KA. Effects of alcohol tax and price policies on morbidity and mortality: a systematic review. Am J Public Health. 2010;100(11):2270–8.PubMedPubMedCentralCrossRef Wagenaar AC, Tobler AL, Komro KA. Effects of alcohol tax and price policies on morbidity and mortality: a systematic review. Am J Public Health. 2010;100(11):2270–8.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Miracolo A, Sophiea M, Mills M, Kanavos P. Sin taxes and their effect on consumption, revenue generation and health improvement: a systematic literature review in Latin America. Health Policy Plan. 2021;36(5):790–810.PubMedPubMedCentralCrossRef Miracolo A, Sophiea M, Mills M, Kanavos P. Sin taxes and their effect on consumption, revenue generation and health improvement: a systematic literature review in Latin America. Health Policy Plan. 2021;36(5):790–810.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat van Schalkwyk MC, Petticrew M, Cassidy R, Adams P, McKee M, Reynolds J, et al. A public health approach to gambling regulation: countering powerful influences. Lancet Public Health. 2021;6(8):e614–9.PubMedCrossRef van Schalkwyk MC, Petticrew M, Cassidy R, Adams P, McKee M, Reynolds J, et al. A public health approach to gambling regulation: countering powerful influences. Lancet Public Health. 2021;6(8):e614–9.PubMedCrossRef
31.
Zurück zum Zitat Regan M, Smolar M, Burton R, Clarke Z, Sharpe C, Henn C, et al. Policies and interventions to reduce harmful gambling: an international Delphi consensus and implementation rating study. Lancet Public Health. 2022;7(8):e705–17.PubMedCrossRef Regan M, Smolar M, Burton R, Clarke Z, Sharpe C, Henn C, et al. Policies and interventions to reduce harmful gambling: an international Delphi consensus and implementation rating study. Lancet Public Health. 2022;7(8):e705–17.PubMedCrossRef
32.
Zurück zum Zitat Burton R, Jecks M, Sheron N, Henn C, Sharpe C, Regan M, et al. The relationship between the price of alcohol, tobacco, high fat salt sugar (HFSS) food/drink, and gambling on demand and mortality: a rapid systematic review of systematic reviews. 2023. Burton R, Jecks M, Sheron N, Henn C, Sharpe C, Regan M, et al. The relationship between the price of alcohol, tobacco, high fat salt sugar (HFSS) food/drink, and gambling on demand and mortality: a rapid systematic review of systematic reviews. 2023.
33.
Zurück zum Zitat Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.PubMedCrossRef Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.PubMedCrossRef
34.
Zurück zum Zitat Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):1–10.CrossRef Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):1–10.CrossRef
35.
Zurück zum Zitat Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.PubMedPubMedCentralCrossRef Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–34.PubMedPubMedCentralCrossRef Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–34.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Banzi R, Cinquini M, Gonzalez-Lorenzo M, Pecoraro V, Capobussi M, Minozzi S. Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability. J Clin Epidemiol. 2018;99:24–32.PubMedCrossRef Banzi R, Cinquini M, Gonzalez-Lorenzo M, Pecoraro V, Capobussi M, Minozzi S. Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability. J Clin Epidemiol. 2018;99:24–32.PubMedCrossRef
38.
Zurück zum Zitat Perry R, Whitmarsh A, Leach V, Davies P. A comparison of two assessment tools used in overviews of systematic reviews: ROBIS versus AMSTAR-2. Syst Rev. 2021;10:1–20.CrossRef Perry R, Whitmarsh A, Leach V, Davies P. A comparison of two assessment tools used in overviews of systematic reviews: ROBIS versus AMSTAR-2. Syst Rev. 2021;10:1–20.CrossRef
39.
Zurück zum Zitat Swierz MJ, Storman D, Zajac J, Koperny M, Weglarz P, Staskiewicz W, et al. Similarities, reliability and gaps in assessing the quality of conduct of systematic reviews using AMSTAR-2 and ROBIS: systematic survey of nutrition reviews. BMC Med Res Methodol. 2021;21:1–10.CrossRef Swierz MJ, Storman D, Zajac J, Koperny M, Weglarz P, Staskiewicz W, et al. Similarities, reliability and gaps in assessing the quality of conduct of systematic reviews using AMSTAR-2 and ROBIS: systematic survey of nutrition reviews. BMC Med Res Methodol. 2021;21:1–10.CrossRef
40.
Zurück zum Zitat Alagiyawanna A, Townsend N, Mytton O, Scarborough P, Roberts N, Rayner M. Studying the consumption and health outcomes of fiscal interventions (taxes and subsidies) on food and beverages in countries of different income classifications; a systematic review. BMC Public Health. 2015;15(1):1–14.CrossRef Alagiyawanna A, Townsend N, Mytton O, Scarborough P, Roberts N, Rayner M. Studying the consumption and health outcomes of fiscal interventions (taxes and subsidies) on food and beverages in countries of different income classifications; a systematic review. BMC Public Health. 2015;15(1):1–14.CrossRef
41.
Zurück zum Zitat Backholer K, Sarink D, Beauchamp A, Keating C, Loh V, Ball K, et al. The impact of a tax on sugar-sweetened beverages according to socio-economic position: a systematic review of the evidence. Public Health Nutr. 2016;19(17):3070–84.PubMedPubMedCentralCrossRef Backholer K, Sarink D, Beauchamp A, Keating C, Loh V, Ball K, et al. The impact of a tax on sugar-sweetened beverages according to socio-economic position: a systematic review of the evidence. Public Health Nutr. 2016;19(17):3070–84.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Itria A, Borges SS, Rinaldi AEM, Nucci LB, Enes CC. Taxing sugar-sweetened beverages as a policy to reduce overweight and obesity in countries of different income classifications: a systematic review. Public Health Nutr. 2021;24(16):5550–60.PubMedPubMedCentralCrossRef Itria A, Borges SS, Rinaldi AEM, Nucci LB, Enes CC. Taxing sugar-sweetened beverages as a policy to reduce overweight and obesity in countries of different income classifications: a systematic review. Public Health Nutr. 2021;24(16):5550–60.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Mackenbach JD, Ibouanga EL, van der Veen MH, Ziesemer KA, Pinho MG. Relation between the food environment and oral health—systematic review. Eur J Pub Health. 2022;32(4):606–16.CrossRef Mackenbach JD, Ibouanga EL, van der Veen MH, Ziesemer KA, Pinho MG. Relation between the food environment and oral health—systematic review. Eur J Pub Health. 2022;32(4):606–16.CrossRef
44.
Zurück zum Zitat Nakhimovsky SS, Feigl AB, Avila C, O’Sullivan G, Macgregor-Skinner E, Spranca M. Taxes on sugar-sweetened beverages to reduce overweight and obesity in middle-income countries: a systematic review. PLoS ONE. 2016;11(9):e0163358.PubMedPubMedCentralCrossRef Nakhimovsky SS, Feigl AB, Avila C, O’Sullivan G, Macgregor-Skinner E, Spranca M. Taxes on sugar-sweetened beverages to reduce overweight and obesity in middle-income countries: a systematic review. PLoS ONE. 2016;11(9):e0163358.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Nikniaz L, Tabrizi JS, Farhangi MA, Pourmoradian S, Allameh M, Hoseinifard H, et al. Community-based Interventions to reduce fat intake in healthy populations: a systematic review and meta-analysis. Curr Nutr Food Sci. 2022;18(7):649–69.CrossRef Nikniaz L, Tabrizi JS, Farhangi MA, Pourmoradian S, Allameh M, Hoseinifard H, et al. Community-based Interventions to reduce fat intake in healthy populations: a systematic review and meta-analysis. Curr Nutr Food Sci. 2022;18(7):649–69.CrossRef
46.
Zurück zum Zitat Pérez-Ferrer C, Auchincloss AH, de Menezes MC, Kroker-Lobos MF, de Oliveira CL, Barrientos-Gutierrez T. The food environment in Latin America: a systematic review with a focus on environments relevant to obesity and related chronic diseases. Public Health Nutr. 2019;22(18):3447–64.PubMedPubMedCentralCrossRef Pérez-Ferrer C, Auchincloss AH, de Menezes MC, Kroker-Lobos MF, de Oliveira CL, Barrientos-Gutierrez T. The food environment in Latin America: a systematic review with a focus on environments relevant to obesity and related chronic diseases. Public Health Nutr. 2019;22(18):3447–64.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Redondo M, Hernández-Aguado I, Lumbreras B. The impact of the tax on sweetened beverages: a systematic review. Am J Clin Nutr. 2018;108(3):548–63.PubMedCrossRef Redondo M, Hernández-Aguado I, Lumbreras B. The impact of the tax on sweetened beverages: a systematic review. Am J Clin Nutr. 2018;108(3):548–63.PubMedCrossRef
48.
Zurück zum Zitat von Philipsborn P, Stratil JM, Burns J, Busert LK, Pfadenhauer LM, Polus S, Holzapfel C, Hauner H, Rehfuess E. Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health. Cochrane Database Syst Rev. 2019(6):CD012292. https://doi.org/10.1002/14651858.CD012292.pub2. von Philipsborn P, Stratil JM, Burns J, Busert LK, Pfadenhauer LM, Polus S, Holzapfel C, Hauner H, Rehfuess E. Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health. Cochrane Database Syst Rev. 2019(6):CD012292. https://​doi.​org/​10.​1002/​14651858.​CD012292.​pub2.
49.
Zurück zum Zitat Andreyeva T, Marple K, Moore TE, Powell LM. Evaluation of economic and health outcomes associated with food taxes and subsidies: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(6):e2214371.PubMedPubMedCentralCrossRef Andreyeva T, Marple K, Moore TE, Powell LM. Evaluation of economic and health outcomes associated with food taxes and subsidies: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(6):e2214371.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Dodd R, Santos JA, Tan M, Campbell NR, Ni Mhurchu C, Cobb L, et al. Effectiveness and feasibility of taxing salt and foods high in sodium: a systematic review of the evidence. Adv Nutr. 2020;11(6):1616–30.PubMedPubMedCentralCrossRef Dodd R, Santos JA, Tan M, Campbell NR, Ni Mhurchu C, Cobb L, et al. Effectiveness and feasibility of taxing salt and foods high in sodium: a systematic review of the evidence. Adv Nutr. 2020;11(6):1616–30.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Engler-Stringer R, Le H, Gerrard A, Muhajarine N. The community and consumer food environment and children’s diet: a systematic review. BMC Public Health. 2014;14(1):1–15.CrossRef Engler-Stringer R, Le H, Gerrard A, Muhajarine N. The community and consumer food environment and children’s diet: a systematic review. BMC Public Health. 2014;14(1):1–15.CrossRef
52.
Zurück zum Zitat Holsten JE. Obesity and the community food environment: a systematic review. Public Health Nutr. 2009;12(3):397–405.PubMed Holsten JE. Obesity and the community food environment: a systematic review. Public Health Nutr. 2009;12(3):397–405.PubMed
53.
Zurück zum Zitat Lhachimi SK, Pega F, Heise TL, Fenton C, Gartlehner G, Griebler U, et al. Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes. Cochrane Database Syst Rev. 2020;9(9):CD012415.PubMed Lhachimi SK, Pega F, Heise TL, Fenton C, Gartlehner G, Griebler U, et al. Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes. Cochrane Database Syst Rev. 2020;9(9):CD012415.PubMed
54.
Zurück zum Zitat Mah CL, Luongo G, Hasdell R, Taylor NG, Lo BK. A systematic review of the effect of retail food environment interventions on diet and health with a focus on the enabling role of public policies. Curr Nutr Rep. 2019;8:411–28.PubMedPubMedCentralCrossRef Mah CL, Luongo G, Hasdell R, Taylor NG, Lo BK. A systematic review of the effect of retail food environment interventions on diet and health with a focus on the enabling role of public policies. Curr Nutr Rep. 2019;8:411–28.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Mizdrak A, Scarborough P, Waterlander WE, Rayner M. Differential responses to food price changes by personal characteristic: a systematic review of experimental studies. PLoS ONE. 2015;10(7):e0130320.PubMedPubMedCentralCrossRef Mizdrak A, Scarborough P, Waterlander WE, Rayner M. Differential responses to food price changes by personal characteristic: a systematic review of experimental studies. PLoS ONE. 2015;10(7):e0130320.PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Pfinder M, Heise TL, Boon MH, Pega F, Fenton C, Griebler U, et al. Taxation of unprocessed sugar or sugar-added foods for reducing their consumption and preventing obesity or other adverse health outcomes. Cochrane Database Syst Rev. 2020;4(4):CD012333.PubMed Pfinder M, Heise TL, Boon MH, Pega F, Fenton C, Griebler U, et al. Taxation of unprocessed sugar or sugar-added foods for reducing their consumption and preventing obesity or other adverse health outcomes. Cochrane Database Syst Rev. 2020;4(4):CD012333.PubMed
57.
Zurück zum Zitat Thow AM, Downs S, Jan S. A systematic review of the effectiveness of food taxes and subsidies to improve diets: understanding the recent evidence. Nutr Rev. 2014;72(9):551–65.PubMedCrossRef Thow AM, Downs S, Jan S. A systematic review of the effectiveness of food taxes and subsidies to improve diets: understanding the recent evidence. Nutr Rev. 2014;72(9):551–65.PubMedCrossRef
58.
Zurück zum Zitat Mackenbach JD, Nelissen KG, Dijkstra SC, Poelman MP, Daams JG, Leijssen JB, et al. A systematic review on socioeconomic differences in the association between the food environment and dietary behaviors. Nutrients. 2019;11(9):2215.PubMedPubMedCentralCrossRef Mackenbach JD, Nelissen KG, Dijkstra SC, Poelman MP, Daams JG, Leijssen JB, et al. A systematic review on socioeconomic differences in the association between the food environment and dietary behaviors. Nutrients. 2019;11(9):2215.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Maniadakis N, Kapaki V, Damianidi L, Kourlaba G. A systematic review of the effectiveness of taxes on nonalcoholic beverages and high-in-fat foods as a means to prevent obesity trends. ClinicoEconomics Outcomes Res. 2013;5:519–43.CrossRef Maniadakis N, Kapaki V, Damianidi L, Kourlaba G. A systematic review of the effectiveness of taxes on nonalcoholic beverages and high-in-fat foods as a means to prevent obesity trends. ClinicoEconomics Outcomes Res. 2013;5:519–43.CrossRef
60.
Zurück zum Zitat Niebylski ML, Redburn KA, Duhaney T, Campbell NR. Healthy food subsidies and unhealthy food taxation: a systematic review of the evidence. Nutrition. 2015;31(6):787–95.PubMedCrossRef Niebylski ML, Redburn KA, Duhaney T, Campbell NR. Healthy food subsidies and unhealthy food taxation: a systematic review of the evidence. Nutrition. 2015;31(6):787–95.PubMedCrossRef
61.
62.
Zurück zum Zitat Powell LM, Chriqui JF, Khan T, Wada R, Chaloupka FJ. Assessing the potential effectiveness of food and beverage taxes and subsidies for improving public health: a systematic review of prices, demand and body weight outcomes. Obes Rev. 2013;14(2):110–28.PubMedCrossRef Powell LM, Chriqui JF, Khan T, Wada R, Chaloupka FJ. Assessing the potential effectiveness of food and beverage taxes and subsidies for improving public health: a systematic review of prices, demand and body weight outcomes. Obes Rev. 2013;14(2):110–28.PubMedCrossRef
63.
Zurück zum Zitat Thow AM, Jan S, Leeder S, Swinburn B. The effect of fiscal policy on diet, obesity and chronic disease: a systematic review. Bull World Health Organ. 2010;88:609–14.PubMedPubMedCentralCrossRef Thow AM, Jan S, Leeder S, Swinburn B. The effect of fiscal policy on diet, obesity and chronic disease: a systematic review. Bull World Health Organ. 2010;88:609–14.PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat Wright A, Smith KE, Hellowell M. Policy lessons from health taxes: a systematic review of empirical studies. BMC Public Health. 2017;17(1):1–14.CrossRef Wright A, Smith KE, Hellowell M. Policy lessons from health taxes: a systematic review of empirical studies. BMC Public Health. 2017;17(1):1–14.CrossRef
65.
Zurück zum Zitat Akter S, Islam MR, Rahman MM, Rouyard T, Nsashiyi RS, Hossain F, et al. Evaluation of population-level tobacco control interventions and health outcomes: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(7):e2322341.PubMedPubMedCentralCrossRef Akter S, Islam MR, Rahman MM, Rouyard T, Nsashiyi RS, Hossain F, et al. Evaluation of population-level tobacco control interventions and health outcomes: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(7):e2322341.PubMedPubMedCentralCrossRef
66.
Zurück zum Zitat Hill S, Amos A, Clifford D, Platt S. Impact of tobacco control interventions on socioeconomic inequalities in smoking: review of the evidence. Tob Control. 2014;23(e2):e89–97.PubMedCrossRef Hill S, Amos A, Clifford D, Platt S. Impact of tobacco control interventions on socioeconomic inequalities in smoking: review of the evidence. Tob Control. 2014;23(e2):e89–97.PubMedCrossRef
67.
Zurück zum Zitat Kjeld SG, Jørgensen MB, Aundal M, Bast LS. Price elasticity of demand for cigarettes among youths in high-income countries: a systematic review. Scand J Public Health. 2023;51(1):35–43.PubMedCrossRef Kjeld SG, Jørgensen MB, Aundal M, Bast LS. Price elasticity of demand for cigarettes among youths in high-income countries: a systematic review. Scand J Public Health. 2023;51(1):35–43.PubMedCrossRef
69.
Zurück zum Zitat Nazar GP, Sharma N, Chugh A, Abdullah S, Lina S, Mdege ND, et al. Impact of tobacco price and taxation on affordability and consumption of tobacco products in the South-East Asia Region: a systematic review. Tob Induc Dis. 2021;19:97.PubMedPubMedCentralCrossRef Nazar GP, Sharma N, Chugh A, Abdullah S, Lina S, Mdege ND, et al. Impact of tobacco price and taxation on affordability and consumption of tobacco products in the South-East Asia Region: a systematic review. Tob Induc Dis. 2021;19:97.PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Thomas S, Fayter D, Misso K, Ogilvie D, Petticrew M, Sowden A, et al. Population tobacco control interventions and their effects on social inequalities in smoking: systematic review. Tob Control. 2008;17(4):230–7.PubMedCrossRef Thomas S, Fayter D, Misso K, Ogilvie D, Petticrew M, Sowden A, et al. Population tobacco control interventions and their effects on social inequalities in smoking: systematic review. Tob Control. 2008;17(4):230–7.PubMedCrossRef
71.
Zurück zum Zitat Wilson LM, Avila Tang E, Chander G, Hutton HE, Odelola OA, Elf JL, et al. Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review. J Environ Public Health. 2012;2012:961724.PubMedPubMedCentralCrossRef Wilson LM, Avila Tang E, Chander G, Hutton HE, Odelola OA, Elf JL, et al. Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review. J Environ Public Health. 2012;2012:961724.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Baldwin R, Miller PG, Coomber K, Patafio B, Scott D. A systematic narrative review of the effects of alcohol supply reduction policies on children and adolescents. Int J Drug Policy. 2022;101:103581.PubMedCrossRef Baldwin R, Miller PG, Coomber K, Patafio B, Scott D. A systematic narrative review of the effects of alcohol supply reduction policies on children and adolescents. Int J Drug Policy. 2022;101:103581.PubMedCrossRef
73.
Zurück zum Zitat Elder RW, Lawrence B, Ferguson A, Naimi TS, Brewer RD, Chattopadhyay SK, et al. The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms. Am J Prev Med. 2010;38(2):217–29.PubMedPubMedCentralCrossRef Elder RW, Lawrence B, Ferguson A, Naimi TS, Brewer RD, Chattopadhyay SK, et al. The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms. Am J Prev Med. 2010;38(2):217–29.PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Kõlves K, Chitty KM, Wardhani R, Värnik A, De Leo D, Witt K. Impact of alcohol policies on suicidal behavior: a systematic literature review. Int J Environ Res Public Health. 2020;17(19):7030.PubMedPubMedCentralCrossRef Kõlves K, Chitty KM, Wardhani R, Värnik A, De Leo D, Witt K. Impact of alcohol policies on suicidal behavior: a systematic literature review. Int J Environ Res Public Health. 2020;17(19):7030.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Li Q, Babor TF, Zeigler D, Xuan Z, Morisky D, Hovell MF, et al. Health promotion interventions and policies addressing excessive alcohol use: a systematic review of national and global evidence as a guide to health-care reform in China. Addiction. 2015;110:68–78.PubMedPubMedCentralCrossRef Li Q, Babor TF, Zeigler D, Xuan Z, Morisky D, Hovell MF, et al. Health promotion interventions and policies addressing excessive alcohol use: a systematic review of national and global evidence as a guide to health-care reform in China. Addiction. 2015;110:68–78.PubMedPubMedCentralCrossRef
76.
Zurück zum Zitat Scott S, Muirhead C, Shucksmith J, Tyrrell R, Kaner E. Does industry-driven alcohol marketing influence adolescent drinking behaviour? A systematic review. Alcohol Alcohol. 2017;52(1):84–94.PubMedCrossRef Scott S, Muirhead C, Shucksmith J, Tyrrell R, Kaner E. Does industry-driven alcohol marketing influence adolescent drinking behaviour? A systematic review. Alcohol Alcohol. 2017;52(1):84–94.PubMedCrossRef
77.
Zurück zum Zitat Wilson IM, Graham K, Taft A. Alcohol interventions, alcohol policy and intimate partner violence: a systematic review. BMC Public Health. 2014;14:1–11.CrossRef Wilson IM, Graham K, Taft A. Alcohol interventions, alcohol policy and intimate partner violence: a systematic review. BMC Public Health. 2014;14:1–11.CrossRef
78.
Zurück zum Zitat Bader P, Boisclair D, Ferrence R. Effects of tobacco taxation and pricing on smoking behavior in high risk populations: a knowledge synthesis. Int J Environ Res Public Health. 2011;8(11):4118–39.PubMedPubMedCentralCrossRef Bader P, Boisclair D, Ferrence R. Effects of tobacco taxation and pricing on smoking behavior in high risk populations: a knowledge synthesis. Int J Environ Res Public Health. 2011;8(11):4118–39.PubMedPubMedCentralCrossRef
79.
Zurück zum Zitat Lewin S, Glenton C, Munthe-Kaas H, Carlsen B, Colvin CJ, Gülmezoglu M, et al. Using qualitative evidence in decision making for health and social interventions: an approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Med. 2015;12(10):e1001895.PubMedPubMedCentralCrossRef Lewin S, Glenton C, Munthe-Kaas H, Carlsen B, Colvin CJ, Gülmezoglu M, et al. Using qualitative evidence in decision making for health and social interventions: an approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Med. 2015;12(10):e1001895.PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Andreyeva T, Long MW, Brownell KD. The impact of food prices on consumption: a systematic review of research on the price elasticity of demand for food. Am J Public Health. 2010;100(2):216–22.PubMedPubMedCentralCrossRef Andreyeva T, Long MW, Brownell KD. The impact of food prices on consumption: a systematic review of research on the price elasticity of demand for food. Am J Public Health. 2010;100(2):216–22.PubMedPubMedCentralCrossRef
81.
Zurück zum Zitat Action on Smoking and Health. Taxation of tobacco and related products. 2023. Action on Smoking and Health. Taxation of tobacco and related products. 2023.
82.
Zurück zum Zitat Yeomans H. Regulating drinking through alcohol taxation and minimum unit pricing: a historical perspective on alcohol pricing interventions. Regul Govern. 2019;13(1):3–17.CrossRef Yeomans H. Regulating drinking through alcohol taxation and minimum unit pricing: a historical perspective on alcohol pricing interventions. Regul Govern. 2019;13(1):3–17.CrossRef
84.
Zurück zum Zitat Salgado Hernández JC, Ng SW, Colchero MA. Changes in sugar-sweetened beverage purchases across the price distribution after the implementation of a tax in Mexico: a before-and-after analysis. BMC Public Health. 2023;23(1):265.PubMedPubMedCentralCrossRef Salgado Hernández JC, Ng SW, Colchero MA. Changes in sugar-sweetened beverage purchases across the price distribution after the implementation of a tax in Mexico: a before-and-after analysis. BMC Public Health. 2023;23(1):265.PubMedPubMedCentralCrossRef
85.
Zurück zum Zitat Goyder E, Blank L, Baxter S, van Schalkwyk MC. Tackling gambling related harms as a public health issue. Lancet Public Health. 2020;5(1):e14–5.PubMedCrossRef Goyder E, Blank L, Baxter S, van Schalkwyk MC. Tackling gambling related harms as a public health issue. Lancet Public Health. 2020;5(1):e14–5.PubMedCrossRef
86.
Zurück zum Zitat Sulkunen P, Babor TF, Cisneros Örnberg J, Egerer M, Hellman M, Livingstone C, et al. Setting limits: gambling, science and public policy—summary of results. Addiction. 2021;116(1):32–40.PubMedCrossRef Sulkunen P, Babor TF, Cisneros Örnberg J, Egerer M, Hellman M, Livingstone C, et al. Setting limits: gambling, science and public policy—summary of results. Addiction. 2021;116(1):32–40.PubMedCrossRef
87.
Zurück zum Zitat Newall P, Rockloff M. Risks of using taxation as a public health measure to reduce gambling-related harms. 2022. Newall P, Rockloff M. Risks of using taxation as a public health measure to reduce gambling-related harms. 2022.
89.
90.
Zurück zum Zitat Organization for Economic Cooperation and Development. Preventing harmful alcohol use. Paris: OECD Publishing; 2021. Organization for Economic Cooperation and Development. Preventing harmful alcohol use. Paris: OECD Publishing; 2021.
91.
Zurück zum Zitat Brennan A, Meier P, Purshouse R, Rafia R, Meng Y, Hill-Macmanus D, et al. The Sheffield alcohol policy model – a mathematical description. Health Econ. 2015;24(10):1368–88.PubMedCrossRef Brennan A, Meier P, Purshouse R, Rafia R, Meng Y, Hill-Macmanus D, et al. The Sheffield alcohol policy model – a mathematical description. Health Econ. 2015;24(10):1368–88.PubMedCrossRef
92.
Zurück zum Zitat Angus C, Gillespie D, Ally AK, Brennan A. Modelling the impact of minimum unit price and Identification and brief advice policies using the Sheffield alcohol policy model version 3. 2015. Angus C, Gillespie D, Ally AK, Brennan A. Modelling the impact of minimum unit price and Identification and brief advice policies using the Sheffield alcohol policy model version 3. 2015.
93.
Zurück zum Zitat O’Donnell A, Anderson P, Jané-Llopis E, Manthey J, Kaner E, Rehm J. Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015–18. BMJ. 2019;366:l5274.PubMedPubMedCentralCrossRef O’Donnell A, Anderson P, Jané-Llopis E, Manthey J, Kaner E, Rehm J. Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015–18. BMJ. 2019;366:l5274.PubMedPubMedCentralCrossRef
95.
Zurück zum Zitat Shield K, Paradis C, Butt P, Naimi T, Sherk A, Asbridge M, et al. New perspectives on how to formulate alcohol drinking guidelines. Addiction. 2024;119(1):9–19.PubMedCrossRef Shield K, Paradis C, Butt P, Naimi T, Sherk A, Asbridge M, et al. New perspectives on how to formulate alcohol drinking guidelines. Addiction. 2024;119(1):9–19.PubMedCrossRef
96.
Zurück zum Zitat Conigrave KM, Ali RL, Armstrong R, Chikritzhs TN, d’Abbs P, Harris MF, et al. Revision of the Australian guidelines to reduce health risks from drinking alcohol. Med J Aust. 2021;215(11):518–24.PubMedPubMedCentralCrossRef Conigrave KM, Ali RL, Armstrong R, Chikritzhs TN, d’Abbs P, Harris MF, et al. Revision of the Australian guidelines to reduce health risks from drinking alcohol. Med J Aust. 2021;215(11):518–24.PubMedPubMedCentralCrossRef
97.
Zurück zum Zitat Holmes J, Angus C, Meier PS, Buykx P, Brennan A. How should we set consumption thresholds for low risk drinking guidelines? Achieving objectivity and transparency using evidence, expert judgement and pragmatism. Addiction. 2019;114(4):590–600.PubMedCrossRef Holmes J, Angus C, Meier PS, Buykx P, Brennan A. How should we set consumption thresholds for low risk drinking guidelines? Achieving objectivity and transparency using evidence, expert judgement and pragmatism. Addiction. 2019;114(4):590–600.PubMedCrossRef
98.
Zurück zum Zitat Meng Y, Brennan A, Purshouse R, Hill-McManus D, Angus C, Holmes J, et al. Estimation of own and cross price elasticities of alcohol demand in the UK—a pseudo-panel approach using the Living Costs and Food Survey 2001–2009(). J Health Econ. 2014;34(100):96–103.PubMedPubMedCentralCrossRef Meng Y, Brennan A, Purshouse R, Hill-McManus D, Angus C, Holmes J, et al. Estimation of own and cross price elasticities of alcohol demand in the UK—a pseudo-panel approach using the Living Costs and Food Survey 2001–2009(). J Health Econ. 2014;34(100):96–103.PubMedPubMedCentralCrossRef
99.
Zurück zum Zitat Tauras JA, Chaloupka FJ. The demand for nicotine replacement therapies. Nicotine Tob Res. 2003;5(2):237–43.PubMedCrossRef Tauras JA, Chaloupka FJ. The demand for nicotine replacement therapies. Nicotine Tob Res. 2003;5(2):237–43.PubMedCrossRef
100.
Zurück zum Zitat Grace RC, Kivell BM, Laugesen M. Estimating cross-price elasticity of e-cigarettes using a simulated demand procedure. Nicotine Tob Res. 2014;17(5):592–8.PubMedCrossRef Grace RC, Kivell BM, Laugesen M. Estimating cross-price elasticity of e-cigarettes using a simulated demand procedure. Nicotine Tob Res. 2014;17(5):592–8.PubMedCrossRef
101.
Zurück zum Zitat Page MJ, Moher D. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement and extensions: a scoping review. Syst Rev. 2017;6(1):263.PubMedPubMedCentralCrossRef Page MJ, Moher D. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement and extensions: a scoping review. Syst Rev. 2017;6(1):263.PubMedPubMedCentralCrossRef
Metadaten
Titel
The relationship between the price and demand of alcohol, tobacco, unhealthy food, sugar-sweetened beverages, and gambling: an umbrella review of systematic reviews
verfasst von
Robyn Burton
Casey Sharpe
Saloni Bhuptani
Mike Jecks
Clive Henn
Nicola Pearce-Smith
Sandy Knight
Marguerite Regan
Nick Sheron
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2024
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18599-3

Weitere Artikel der Ausgabe 1/2024

BMC Public Health 1/2024 Zur Ausgabe